RML Hospital recalls 10 drug batches after quality failures

The Story in Brief

Dr Ram Manohar Lohia Hospital in New Delhi has recalled 10 batches of medicines after they were found to be ‘Not of Standard Quality’ (NSQ) or had physical defects. The affected drugs include sodium valproate, spironolactone, imipramine, metoprolol, methyl ergometrine, adenosine, multivitamin injection, pheniramine maleate and ascorbic acid, used to treat seizures, heart conditions, depression, rapid heart rhythms and postpartum bleeding.

Four notices issued between 7 and 14 September directed departments to stop using the batches and return them. Three tablet batches and five injectable batches failed analytical testing, while two tablet batches, isosorbide mononitrate 20 mg and metoprolol 50 mg, were found in powder form inside the strip. The defective tablets were made by Glowson India Labs Pvt Ltd. Some samples were supplied by M/s Jackson Laboratories Pvt Ltd, hospital officials said.

The hospital said no severe adverse effects had been reported so far. Alternative medicines have been arranged to avoid disruption in patient care. The NSQ batches were to be returned by 18 September, while defective tablets were to be returned within three days of the notices.

Update, 3 October 2026: Times Now and Business Standard now also report the recall. Times Now names the five injectable batches and confirms that some samples were supplied by M/s Jackson Laboratories Pvt Ltd. Business Standard notes that eight batches failed analytical testing while two had visible physical defects. All three outlets confirm no severe adverse effects have been reported.

Indian Opinion Analysis

All three outlets report the same facts in near-identical wire-style copy, each attributing details to The Times of India and RML officials. The uniform coverage centres on the hospital’s proactive recall, the list of 10 affected batches, the manufacturers named, and the reassurance that no severe adverse effects have been reported. Business Standard leads with the NSQ classification and the scale of failures across oral and injectable drugs, while Times Now adds a sidebar on the clinical uses of each medicine. The absence of any critical or questioning framing across the three reports suggests a shared reliance on the hospital’s official account. The concrete next step, the return deadlines of 18 September and three days from each notice, is confirmed by all sources.

Coverage: 3 sources, 3 neutral


Sources (3): timesofindia.indiatimes.com (neutral report), timesnownews.com (neutral report), business-standard.com (neutral report)

This brief was synthesised by AI from the 3 sources linked above, so one read covers every framing they carry. Methodology and corrections.

Ask their opinion on this story
They have read this article, our coverage, and the web.
AI simulations of historical figures. Responses are generated from the historical record, not authentic statements.

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Share your opinion

Sign in to comment

Comments are open to readers with an Indian Opinion account. We email you a 6-digit code; there is no password.

Sign in to comment

Loading Next Post...
Search Trending
Ask their opinion
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

All fields are required.